GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $1.72 $2.31 Thursday, 18th Apr 2024 CTMX stock ended at $1.73. This is 1.70% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.92% from a day low at $1.72 to a day high of $1.79.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
2021-04-26 $9.22 $9.60 $9.01 $9.49 731 353
2021-04-23 $8.77 $9.25 $8.64 $9.16 1 147 977
2021-04-22 $8.48 $9.04 $8.33 $8.96 1 116 390
2021-04-21 $8.02 $8.56 $7.67 $8.53 889 003
2021-04-20 $7.59 $8.00 $7.43 $7.96 648 538
2021-04-19 $7.41 $7.65 $7.39 $7.60 579 008
2021-04-16 $7.71 $7.72 $7.23 $7.51 938 174
2021-04-15 $7.51 $7.68 $7.35 $7.65 1 146 239
2021-04-14 $6.85 $7.25 $6.85 $7.22 1 273 302
2021-04-13 $6.85 $6.91 $6.50 $6.83 1 137 946
2021-04-12 $7.67 $7.77 $6.73 $6.74 1 512 895
2021-04-09 $7.80 $7.80 $7.53 $7.72 1 001 609
2021-04-08 $7.71 $7.85 $7.64 $7.81 669 128
2021-04-07 $8.10 $8.17 $7.58 $7.60 588 292
2021-04-06 $8.42 $8.42 $8.11 $8.19 1 063 552
2021-04-05 $7.92 $8.40 $7.82 $8.38 832 570
2021-04-01 $7.81 $8.10 $7.65 $7.87 437 493
2021-03-31 $7.44 $7.82 $7.35 $7.73 897 542
2021-03-30 $7.50 $7.74 $7.31 $7.40 612 264
2021-03-29 $8.02 $8.08 $7.56 $7.59 991 995
2021-03-26 $7.96 $7.99 $7.53 $7.62 664 625
2021-03-25 $7.81 $7.95 $7.54 $7.94 867 365
2021-03-24 $8.79 $8.79 $7.88 $7.92 878 342
2021-03-23 $8.80 $9.09 $8.36 $8.76 1 426 473
2021-03-22 $8.18 $8.79 $8.18 $8.52 554 818
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT